Mican, your statement is good for the lawyers that it could be "malpractice to make a patient go through a series of relapses before pona". knowing that there is a 100% chance of mutation in other TKIs versus the AEs in pona, the doctors should give the patients the freedom of choice in treatment. If they don't give patients the choice, they could be liable for malpractice. Others, can you weigh in on this?
News 
Market Data 
Discover 
